Sunday 5th December 2021
Sunday, 5th of December 2021
Home / Tag: TB Alliance

Tag Archives: TB Alliance

World Tuberculosis Day: TB Alliance sublicenses anti-tuberculosis drug

Greg-Perry

Agreement announced on World Tuberculosis Day revitalises efforts to develop sutezolid as effective response to infectious disease killer On Friday, March 24 2017, the World Tuberculosis Day, TB Alliance and the Medicines Patent Pool (MPP) announced a licensing agreement for the clinical development of sutezolid, an antibiotic drug candidate which demonstrated encouraging results in early studies. The sublicense pertains to ...

Read More »

Fresh concern over drug-resistant tuberculosis

TB Alliance and the broader TB community are asking the World Health Organisation (WHO) to add Mycobacterium tuberculosis to the critical group within the list of drug-resistant bacteria identified as urgent priorities for research and development. “The absence of TB from this list is shocking,” said Mel Spigelman, President and CEO of TB Alliance. “The effort to develop new drugs to cure TB has ...

Read More »

TB drug candidate advanced into clinical testing

A TB patient

TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years The Global Alliance for TB Drug Development (TB Alliance) has announced the start of the first human trial of a new tuberculosis (TB) drug candidate, designated TBA-354. It is the first new TB drug candidate to begin a Phase 1 clinical trial since 2009. “There ...

Read More »